Nitrofurantoin and pregnancy [3]

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 13, 2007, Pages 1860-1861

  Cimolai, Nevio ^a   Cimolai, Tomas ^b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NITROFURANTOIN; URINARY TRACT ANTIINFECTIVE AGENT;

CRANIOFACIAL SYNOSTOSIS; DRUG SAFETY; FEMALE; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; LETTER; PREGNANCY; PRENATAL DRUG EXPOSURE; URINARY TRACT INFECTION; NOTE; PREGNANCY COMPLICATION; THIRD TRIMESTER PREGNANCY;

ANTI-INFECTIVE AGENTS, URINARY; FEMALE; HUMANS; NITROFURANTOIN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; URINARY TRACT INFECTIONS;

EID: 34347212470     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.1070028     Document Type: Letter

References (9)

1. Mohamed A, Dresser GK, Mehta S. Acute respiratory failure during pregnancy: a case of nitrofurantoin-induced pneumonitis. CMAJ 2007;176(3):319-20.
2. Le J, Briggs GG, McKeown A, et al. Urinary tract infections during pregnancy. Ann Pharmacother 2004;38:1692-701.
3. Prytherch JP, Sutton ML, Denine EP. General reproduction, perinatal-postnatal, and teratology studies of nitrofurantoin macrocrystals in rats and rabbits. J Toxicol Environ Health 1984;13:811-23.
4. Ben David S, Einarson T, Ben David Y, et al. The safety of nitrofurantoin during the first trimester of pregnancy: meta-analysis. Fundam Clin Pharmacol 1995;9:503-7.
5. Gait JE. Hemolytic reactions to nitrofurantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice. DICP 1990;24: 1210-3.
6. Bruel H, Guillemant V, Saladin-Thiron C, et al. Anémie hémolytique chez un nouveau-né après prise maternelle de nitrofuratoïne en fin de grossesse. Arch Pediatr 2000;7:745-7.
7. Kallen B, Robert-Gnansia E. Maternal drug use, fertility problems, and infant craniostenosis. Cleft Palate Craniofac J 2005;42:589-93.
8. Gardner JS, Guyard-Boileau B, Alderman BW, et al. Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis. Int J Epidemiol 1998;27:64-7.
9. Canadian Pharmacists Association. Canadian compendium of pharmaceuticals and specialties. The Canadian drug reference for health professionals. 42nd ed. Ottawa (ON): The Association; 2007.